Atopic Dermatitis Treatment Market Recent Industry Trends and Project Atopic Dermatitis Treatment Healthcare | Page 4

Atopic Dermatitis Treatment Market
An atopic dermatitis is an unusually public inflammatory disorder of the skin and form of eczema. It may
affect 1 in every 5th individual at any age but is most common in children. These disorders are related to
an increased action of the allergy factor of the immune system. Atopic dermatitis is a type of eczema that
refers to diseases or disorders related to the skin such as itchy, dry, red skin that can sometimes become
crusted, scaling, weeping, and thickened. To control the atopic dermatitis biologic agents must have the
ability to monitor the patient suffering from severe or moderate atopic dermatitis. An atopic dermatitis
diagnosis is subjected to exclusive disorders such as psoriasis, seborrhea dermatitis, scabies, allergic
contact dermatitis, cutaneous lymphoma, and immunodeficiency disorders. Substantial amounts of an
emollient or lubricant cream should be applied to the skin immediately after bathing. To treat atopic
dermatitis emollients should be used topically once or twice daily to inhibit skin irritation and dryness.
Moreover, for night use lubricating ointments may be favored because of their more hydrating
properties. At night wearing socks or cotton gloves may improve these properties. Patients usually desire
to use emollient creams over ointments for daytime use because emollients have a cosmetic, non-greasy
appearance.
Atopic Dermatitis Treatment Market: Divers and Restraints
The major driver for the growth of atopic dermatitis market is the launch of the first biologic for the
treatment of atopic dermatitis. Sanofi and Regeneron successful partnership launched the first biologic
to treat the severe and moderate atopic dermatitis namely dupilumab will give a relief to patient
suffering from atopic dermatitis disorder and will drive the atopic dermatitis treatment market.
©2015 Future Market Insights, All Rights Reserved
4